Approximately 30% of extremely premature infants survive with central nervous system (CNS) damage, including intracranial hemorrhage (ICH), that often occurs in association with intrapartum asphyxia. Prevention of ICH and CNS damage has proven difficult because the causes of CNS injury are multifactorial. One of the associated factors is instability of the cardiovascular system following asphyxia. We hypothesize that intravenous administration of fructose-1,6-bisphosphate (FBP), an intermediary metabolite of glycolysis that reduces gut, myocardial, and lung injury in adults following shock, myocardial ischemia, cardiac arrest, and adult respiratory distress syndrome, will improve the outcome of extremely premature infants, since they have many of these same problems. FBP also has dramatic protective effects on the CNS of adult animals, including increased resuscitation from hypoxia-induced cardiac arrest and reduced cerebral infarct volume (43%) following reversible carotid artery occlusion. However, there are no data on the use of FBP in human infants. Before our hypothesis can be tested in human infants, animal studies must be performed to determine the efficacy, safety, and effective dose in young animals. Four studies are proposed. The first determines whether FBP administration at the end of asphyxia reduces the incidence and severity of ICH in less than 1-day-old asphyxiated Beagle puppies when compared to asphyxiated, saline-treated control animals. The second study determines if administration of 250-1000 mg/kg of FBP stabilizes the cardiovascular system of asphyxiated puppies, as measured by intravascular pressures, cardiac output and cardiac output distribution. (Fluctuations in intravascular pressures are associated with increased ICH in preterm infants.) The third study determines if 250-1000 mg/kg of FBP given intraperitoneally damages kidney, liver, gut, lungs, or brain in normoxic, 7-day-old rats, and if these doses of FBP affect blood electrolytes, calcium and phosphorus content, and renal and hepatic function. The fourth study determines if FBP reduces stroke volume and neuronal injury in a focal ischemia model in 7-day-old rats. If these studies demonstrate efficacy and safety of FBP in young animals, a subsequent application will be made proposing clinical trials of FBP in preterm infants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory Grants (P20)
Project #
5P20NS032553-03
Application #
3738758
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kim, Young S; Honkaniemi, Jari; Sharp, Frank R et al. (2004) Expression of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta in the brain during experimental group B streptococcal meningitis. Brain Res Mol Brain Res 128:95-102
Hajnal, Beatrice Latal; Ferriero, Donna M; Partridge, J Colin et al. (2004) Is exposure to cocaine or cigarette smoke during pregnancy associated with infant visual abnormalities? Dev Med Child Neurol 46:520-5
Loeffler, J M; Ringer, R; Hablutzel, M et al. (2001) The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis 183:247-252
Dempsey, D A; Hajnal, B L; Partridge, J C et al. (2000) Tone abnormalities are associated with maternal cigarette smoking during pregnancy in in utero cocaine-exposed infants. Pediatrics 106:79-85
Leib, S L; Leppert, D; Clements, J et al. (2000) Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 68:615-20
Auer, M; Pfister, L A; Leppert, D et al. (2000) Effects of clinically used antioxidants in experimental pneumococcal meningitis. J Infect Dis 182:347-50
Vexler, Z; Berrios, M; Ursell, P C et al. (1999) Toxicity of fructose-1,6-bisphosphate in developing normoxic rats. Pharmacol Toxicol 84:115-21
Bergeron, M; Evans, S M; Sharp, F R et al. (1999) Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia. Neuroscience 89:1357-66
Dugan, L L; Kim, J S; Zhang, Y et al. (1999) Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem 274:25842-8
Hajnal, B L; Sahebkar-Moghaddam, F; Barnwell, A J et al. (1999) Early prediction of neurologic outcome after perinatal depression. Pediatr Neurol 21:788-93

Showing the most recent 10 out of 32 publications